For athletes with diabetes, continuous glucose monitors are game-changers, helping them avoid dangerous blood sugar crashes ...
The remote patient monitoring (RPM) technology that a patient uses while receiving hospital-at-home care does not follow a ...
The use of a continuous glucose monitor during pregnancy may be more cost-effective than self-monitoring blood glucose for ...
Some experts claim that reducing fluctuations throughout the day can help protect against heart disease, even for people who ...
This study reinforces the significance of intensive glycaemic control and is a paradigm shift in managing the disease and its ...
Monitoring of the body’s blood sugar is essential to the treatment of diabetes. But getting effective glucose readings has ...
Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...
Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.
Using a multistep machine-learning process, researchers synthesised CGM data from DCCT participants by leveraging existing blood glucose (BG) profiles and HbA1c measurements. This process involved ...
DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results